US$ 23.41
glp-1 agonist pharmacology Trends in the Development of Receptor Agonists Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Researchers also found the proportion of users of GLP-1 medications without FDA-approved indications rose from 0.21% in 2019 to 0.37% in 2023

51,88 Accordingly, two studies (Liu et al

doi: 10.1016/j.atherosclerosis.2017.07.014

Peptides 2020;125:170213.ArticlePubMedPMC 19
